Evercore ISI Group Maintains In-Line on Edwards Lifesciences, Raises Price Target to $92
Portfolio Pulse from Benzinga Newsdesk
Evercore ISI Group analyst Vijay Kumar maintains an In-Line rating on Edwards Lifesciences (NYSE:EW) and raises the price target from $86 to $92.
April 04, 2024 | 4:38 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Evercore ISI Group maintains an In-Line rating on Edwards Lifesciences and raises the price target from $86 to $92.
The increase in the price target by Evercore ISI Group reflects a positive outlook on Edwards Lifesciences, suggesting potential upside in the stock's price. This could lead to increased investor confidence and a short-term positive impact on the stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100